James Hoffmann, MD
Ophthalmology · Pine Bluff, ARNPI 1043570757
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 35.3% of the total. Among ophthalmology clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $23.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alcon$668
- Biotissue Holdings Inc.$391
- Ocular Therapeutix, Inc.$282
- Bausch & Lomb Americas Inc.$278
- Mallinckrodt Hospital Products Inc.$146
- plus $603 from 16 others
What the payments were for
- Food & beverage$3,48295%
- Education$401%
- Other$1404%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $1,293 |
| Alcon | 31 | $668 |
| Biotissue Holdings Inc. | 5 | $391 |
| Ocular Therapeutix, Inc. | 10 | $282 |
| Bausch & Lomb Americas Inc. | 9 | $278 |
| Mallinckrodt Hospital Products Inc. | 6 | $146 |
| Novartis | 4 | $80 |
| Thea Pharma Inc. | 3 | $60 |
| Ivantis, Inc | 3 | $55 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $52 |
| Omeros Corporation | 3 | $45 |
| Glaukos Corporation | 2 | $45 |
| Oyster Point Pharma, Inc. | 2 | $43 |
| Rxsight Inc | 2 | $41 |
| Aerie Pharmaceuticals, Inc. | 2 | $34 |
| Sun Pharmaceutical Industries Inc. | 1 | $33 |
| Rayner Intraocular Lenses Limited | 2 | $32 |
| Amgen | 1 | $22 |
| Sight Sciences, Inc. | 1 | $18 |
| Carl Zeiss Meditec USA, Inc. | 1 | $18 |
| Eyepoint US, Inc. | 1 | $14 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$129
- AmnioGraft$129
- Clareon PanOptix Pro$126
- MIEBO$118
- XIIDRA$118
How this compares
$3,662 in reported general payments places this provider in the 90th percentile of 125 ophthalmology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 107 | $94,773 |
| LumiganBimatoprost | 134 | $51,845 |
| RocklatanNetarsudil Mesylat/Latanoprost | 107 | $38,290 |
| XiidraLifitegrast | 23 | $24,435 |
| CombiganBrimonidine Tartrate/Timolol | 49 | $15,534 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 89 | $15,358 |
| Latanoprost | 1,367 | $10,140 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 714 | $9,757 |
| Cyclosporine | 18 | $9,642 |
| Alphagan PBrimonidine Tartrate | 28 | $9,026 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 33 | $7,985 |
| Prednisolone Acetate | 189 | $7,229 |
| VyzultaLatanoprostene Bunod | 12 | $6,721 |
| Brimonidine Tartrate | 398 | $4,877 |
| Travoprost | 21 | $3,181 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $1,293 | $171,178318 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $34 | $38,290107 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $278 | $31,15635 claims |
| AlconSimbrinza | $668 | $7,98533 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $52 | $1,92415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 125 ophthalmology providers in Arkansas.
Other ophthalmology in Pine Bluff
- Mike McFarlandPine Bluff$63K
- Evan NewboltPine Bluff$3K
- Byron WilkesPine Bluff$1K
- Daniel SinesRogers$81K
- Jennifer DoyleLittle Rock$38K
- James LinderMarion$18K
- Matthew MargolisJonesboro$17K
- Thomas StankJonesboro$16K
- Andrew PerinNorth Little Rock$4K
- Jeffrey HoltHot Springs$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.